Mesenchymal stem cell therapy for cardiac inflammation: Immunomodulatory properties and the influence of toll-like receptors

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Van Den Akker, F ^a   De Jager, S C A ^a   Sluijter, J P G ^a,b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

LIGAND; TLR3 PROTEIN, HUMAN; TLR4 PROTEIN, HUMAN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4;

ANIMAL; B LYMPHOCYTE; CELL DIFFERENTIATION; CELL MOTION; CELL PROLIFERATION; CYTOLOGY; HEART INFARCTION; HEART MUSCLE; HUMAN; IMMUNOMODULATION; INFLAMMATION; MACROPHAGE; MESENCHYMAL STROMA CELL; METABOLISM; MONOCYTE; MOUSE; NEUTROPHIL; PATHOLOGY; REVIEW; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION; T LYMPHOCYTE;

ANIMALS; B-LYMPHOCYTES; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; HUMANS; IMMUNOMODULATION; INFLAMMATION; LIGANDS; MACROPHAGES; MESENCHYMAL STROMAL CELLS; MICE; MONOCYTES; MYOCARDIAL INFARCTION; MYOCARDIUM; NEUTROPHILS; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION; T-LYMPHOCYTES; TOLL-LIKE RECEPTOR 3; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTORS;

EID: 84893847470     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/181020     Document Type: Review

References (137)

1. Go A. S., Mozaffarian D., Roger V. L., Executive summary: heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation 2013 127 1 143 152
2. Francis G. S., Pathophysiology of chronic heart failure. The American Journal of Medicine 2001 110 7, supplement 1 37S 46S 10.1016/S0002-9343(98) 00385-4
3. Roubille F., Barrere-Lemaire S., Apoptosis following myocardial infarction: cardiomyocytes and beyond. European Journal of Clinical Investigation 2013 10.1111/eci.12188
4. Oerlemans M. I. F. J., Koudstaal S., Chamuleau S. A., de Kleijn D. P., Doevendans P. A., Sluijter J. P. G., Targeting cell death in the reperfused heart: pharmacological approaches for cardioprotection. International Journal of Cardiology 2012 2-s2.0-84858855472 10.1016/j.ijcard.2012.03.055
5. Frangogiannis N. G., Smith C. W., Entman M. L., The inflammatory response in myocardial infarction. Cardiovascular Research 2002 53 1 31 47 2-s2.0-0036136667 10.1016/S0008-6363(01)00434-5 (Pubitemid 34020764)
6. Hausenloy D. J., Erik Botker H., Condorelli G., Ferdinandy P., Garcia-Dorado D., Heusch G., Lecour S., van Laake L. W., Madonna R., Ruiz-Meana M., Schulz R., Sluijter J. P., Yellon D. M., Ovize M., Translating cardioprotection for patient benefit: position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. Cardiovascular Research 2013 98 1 7 27
7. Linkermann A., Brasen J. H., Darding M., Jin M. K., Sanz A. B., Heller J. O., De Zen F., Weinlich R., Ortiz A., Walczak H., Weinberg J. M., Green D. R., Kunzendorf U., Krautwald S., Two independent pathways of regulated necrosis mediate ischemia-reperfusion injury. Proceedings of the National Academy of Sciences of the United States of America 2013 110 29 12024 12029
8. Harel-Adar T., Ben Mordechai T., Amsalem Y., Feinberg M. S., Leor J., Cohen S., Modulation of cardiac macrophages by phosphatidylserine-presenting liposomes improves infarct repair. Proceedings of the National Academy of Sciences of the United States of America 2011 108 5 1827 1832 2-s2.0-79952176105 10.1073/pnas.1015623108
9. Vilahur G., Juan-Babot O., Peña E., Oñate B., Casaní L., Badimon L., Molecular and cellular mechanisms involved in cardiac remodeling after acute myocardial infarction. Journal of Molecular and Cellular Cardiology 2011 50 3 522 533 2-s2.0-79551614815 10.1016/j.yjmcc.2010.12.021
10. van den Akker F., Deddens J. C., Doevendans P. A., Sluijter J. P., Cardiac stem cell therapy to modulate inflammation upon myocardial infarction. Biochimica et Biophysica Acta 2013 1830 2 2449 2458
11. Frangogiannis N. G., The immune system and cardiac repair. Pharmacological Research 2008 58 2 88 111 2-s2.0-53249095498 10.1016/j.phrs.2008.06.007
12. Frantz S., Bauersachs J., Ertl G., Post-infarct remodelling: contribution of wound healing and inflammation. Cardiovascular Research 2009 81 3 474 481 2-s2.0-59449085857 10.1093/cvr/cvn292
13. Frangogiannis N. G., Regulation of the inflammatory response in cardiac repair. Circulation Research 2012 110 1 159 173 2-s2.0-84855371090 10.1161/CIRCRESAHA.111.243162
14. Zuidema M. Y., Zhang C., Ischemia/reperfusion injury: the role of immune cells. The World Journal of Cardiology 2010 2 10 325 332
15. Arslan F., de Kleijn D. P., Pasterkamp G., Innate immune signaling in cardiac ischemia. Nature Reviews Cardiology 2011 8 5 292 300 2-s2.0-79955484855 10.1038/nrcardio.2011.38
16. Arslan F., de Kleijn D. P. V., Timmers L., Doevendans P. A., Pasterkamp G., Bridging innate immunity and myocardial ischemia/reperfusion injury: the search for therapeutic targets. Current Pharmaceutical Design 2008 14 12 1205 1216 2-s2.0-47149084387 10.2174/138161208784246090 (Pubitemid 351997833)
17. Mill J. G., Stefanon I., dos Santos L., Baldo M. P., Remodeling in the ischemic heart: the stepwise progression for heart failure. Brazilian Journal of Medical and Biological Research 2011 44 9 890 898 2-s2.0-80053318827 10.1590/S0100-879X2011007500096
18. Varda-Bloom N., Leor J., Ohad D. G., Hasin Y., Amar M., Fixler R., Battler A., Eldar M., Hasin D., Cytotoxic T lymphocytes are activated following myocardial infarction and can recognize and kill healthy myocytes in vitro. Journal of Molecular and Cellular Cardiology 2000 32 12 2141 2149 2-s2.0-0034509413 10.1006/jmcc.2000.1261 (Pubitemid 32039766)
19. Maisel A., Cesario D., Baird S., Rehman J., Haghighi P., Carter S., Experimental autoimmune myocarditis produced by adoptive transfer of splenocytes after myocardial infarction. Circulation Research 1998 82 4 458 463 2-s2.0-0032498899 (Pubitemid 28117327)
20. Woodley S. L., McMillan M., Shelby J., Lynch D. H., Roberts L. K., Ensley R. D., Barry W. H., Myocyte injury and contraction abnormalities produced by cytotoxic T lymphocytes. Circulation 1991 83 4 1410 1418 2-s2.0-0025847330
21. Tang T.-T., Yuan J., Zhu Z.-F., Zhang W.-C., Xiao H., Xia N., Yan X.-X., Nie S.-F., Liu J., Zhou S.-F., Li J.-J., Yao R., Liao M.-Y., Tu X., Liao Y.-H., Cheng X., Regulatory T cells ameliorate cardiac remodeling after myocardial infarction. Basic Research in Cardiology 2012 107 1, article 232 1 17 2-s2.0-83655192300 10.1007/s00395-011-0232-6
22. Giugliano G. R., Giugliano R. P., Gibson C. M., Kuntz R. E., Meta-analysis of corticosteroid treatment in acute myocardial infarction. American Journal of Cardiology 2003 91 9 1055 1059 2-s2.0-0037406233 10.1016/S0002-9149(03)00148-6 (Pubitemid 36514919)
23. Sholter D. E., Armstrong P. W., Adverse effects of corticosteroids on the cardiovascular system. Canadian Journal of Cardiology 2000 16 4 505 511 2-s2.0-0034095183 (Pubitemid 30245588)
24. Timmers L., Lim S. K., Arslan F., Armstrong J. S., Hoefer I. E., Doevendans P. A., Piek J. J., El Oakley R. M., Choo A., Lee C. N., Pasterkamp G., de Kleijn D. P. V., Reduction of myocardial infarct size by human mesenchymal stem cell conditioned medium. Stem Cell Research 2007 1 2 129 137 2-s2.0-44349134076 10.1016/j.scr.2008.02.002
25. Hammerman H., Kloner R. A., Schoen F. J., Brown E. J. Jr., Hale S., Braunwald E., Indomethacin-induced scar thinning after experimental myocardial infarction. Circulation 1983 67 6 1290 1295 2-s2.0-0020629087 (Pubitemid 13105352)
26. Brown E. J. Jr., Kloner R. A., Schoen F. J., Hammerman H., Hale S., Braunwald E., Scar thinning due to ibuprofen administration after experimental myocardial infarction. American Journal of Cardiology 1983 51 5 877 883 2-s2.0-0020663258 (Pubitemid 13141984)
27. Gislason G. H., Jacobsen S., Rasmussen J. N., Rasmussen S., Buch P., Friberg J., Schramm T. K., Abildstrom S. Z., Køber L., Madsen M., Torp-Pedersen C., Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction. Circulation 2006 113 25 2906 2913 2-s2.0-33747125484 10.1161/CIRCULATIONAHA.106.616219 (Pubitemid 44297231)
28. Fraccarollo D., Galuppo P., Schraut S., Kneitz S., van Rooijen N., Ertl G., Bauersachs J., Immediate mineralocorticoid receptor blockade improves myocardial infarct healing by modulation of the inflammatory response. Hypertension 2008 51 4 905 914 2-s2.0-41149165892 10.1161/HYPERTENSIONAHA.107. 100941 (Pubitemid 351654703)
29. Litt M. R., Jeremy R. W., Weisman H. F., Winkelstein J. A., Becker L. C., Neutrophil depletion limited to reperfusion reduces myocardial infarct size after 90 minutes of ischemia. Evidence for neutrophil-mediated reperfusion injury. Circulation 1989 80 6 1816 1827 2-s2.0-0024787759 (Pubitemid 20031713)
30. Romson J. L., Hook B. G., Kunkel S. L., Abrams G. D., Schork M. A., Lucchesi B. R., Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog. Circulation 1983 67 5 1016 1023 2-s2.0-0020583038 (Pubitemid 13080480)
31. Rock K. L., Kono H., The inflammatory response to cell death. Annual Review of Pathology: Mechanisms of Disease 2008 3 99 126 2-s2.0-41749104586 10.1146/annurev.pathmechdis.3.121806.151456 (Pubitemid 351488277)
32. Lichtenauer M., Mildner M., Werba G., Beer L., Hoetzenecker K., Baumgartner A., Hasun M., Nickl S., Mitterbauer A., Zimmermann M., Gyongyosi M., Podesser B. K., Klepetko W., Ankersmit H. J., Anti-thymocyte globulin induces neoangiogenesis and preserves cardiac function after experimental myocardial infarction. PLoS ONE 2012 7 12 e52101
33. Zouggari Y., Ait-Oufella H., Bonnin P., Simon T., Sage A. P., Guerin C., Vilar J., Caligiuri G., Tsiantoulas D., Laurans L., Dumeau E., Kotti S., Bruneval P., Charo I. F., Binder C. J., Danchin N., Tedgui A., Tedder T. F., Silvestre J. S., Mallat Z., B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction. Nature Medicine 2013 19 10 1273 1280
34. Segers V. F. M., Lee R. T., Stem-cell therapy for cardiac disease. Nature 2008 451 7181 937 942 2-s2.0-39749105397 10.1038/nature06800 (Pubitemid 351301749)
35. Dimmeler S., Zeiher A. M., Schneider M. D., Unchain my heart: the scientific foundations of cardiac repair. The Journal of Clinical Investigation 2005 115 3 572 583 2-s2.0-14644414788 10.1172/JCI200524283 (Pubitemid 40322227)
36. Noort W. A., Feye D., van den Akker F., Stecher K. D., Chamuleau S. A. J., Sluijter J. P. G., Doevendans P. A., Mesenchymal stromal cells to treat cardiovascular disease: strategies to improve survival and therapeutic results. Panminerva Medica 2010 52 1 27 40 2-s2.0-77954726628
37. Smits A. M., van Laake L. W., den Ouden K., Schreurs C., Szuhai K., van Echteld C. J., Mummery C. L., Doevendans P. A., Goumans M.-J., Human cardiomyocyte progenitor cell transplantation preserves long-term function of the infarcted mouse myocardium. Cardiovascular Research 2009 83 3 527 535 2-s2.0-67651095942 10.1093/cvr/cvp146
38. Tang X.-L., Rokosh G., Sanganalmath S. K., Yuan F., Sato H., Mu J., Dai S., Li C., Chen N., Peng Y., Dawn B., Hunt G., Leri A., Kajstura J., Tiwari S., Shirk G., Anversa P., Bolli R., Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction. Circulation 2010 121 2 293 305 2-s2.0-74949120679 10.1161/CIRCULATIONAHA.109.871905
39. Abdel-Latif A., Bolli R., Tleyjeh I. M., Montori V. M., Perin E. C., Hornung C. A., Zuba-Surma E. K., Al-Mallah M., Dawn B., Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Archives of Internal Medicine 2007 167 10 989 997 2-s2.0-33947305414 10.1001/archinte.167.10.989 (Pubitemid 46835786)
40. van der Spoel T. I. G., Jansen of Lorkeers S. J., Agostoni P., van Belle E., Gyngysi M., Sluijter J. P. G., Cramer M. J., Doevendans P. A., Chamuleau S. A. J., Human relevance of pre-clinical studies in stem cell therapy: systematic review and meta-analysis of large animal models of ischaemic heart disease. Cardiovascular Research 2011 91 4 649 658 2-s2.0-79958162790 10.1093/cvr/cvr113
41. Fisher S. A., Doree C., Brunskill S. J., Mathur A., Martin-Rendon E., Bone marrow stem cell treatment for ischemic heart disease in patients with no option of revascularization: a systematic review and meta-analysis. PLoS ONE 2013 8 6 e64669
42. Gnecchi M., Zhang Z., Ni A., Dzau V. J., Paracrine mechanisms in adult stem cell signaling and therapy. Circulation Research 2008 103 11 1204 1219 2-s2.0-58149347238 10.1161/CIRCRESAHA.108.176826
43. Vrijsen K. R., Chamuleau S. A., Noort W. A., Doevendans P. A., Sluijter J. P., Stem cell therapy for end-stage heart failure: indispensable role for the cell? Current Opinion in Organ Transplantation 2009 14 5 560 565
44. DelaRosa O., Dalemans W., Lombardo E., Toll-like receptors as modulators of mesenchymal stem cells. Frontiers in Immunology 2012 3, article 182
45. Parekkadan B., Milwid J. M., Mesenchymal stem cells as therapeutics. Annual Review of Biomedical Engineering 2010 12 87 117 2-s2.0-77955617561 10.1146/annurev-bioeng-070909-105309
46. Dominici M., le Blanc K., Mueller I., Slaper-Cortenbach I., Marini F. C., Krause D. S., Deans R. J., Keating A., Prockop D. J., Horwitz E. M., Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006 8 4 315 317 2-s2.0-33747713246 10.1080/14653240600855905 (Pubitemid 44269669)
47. Noort W. A., Sluijter J. P. G., Goumans M.-J., Chamuleau S. A. J., Doevendans P. A., Stem cells from in- or outside of the heart: isolation, characterization, and potential for myocardial tissue regeneration. Pediatric Cardiology 2009 30 5 699 709 2-s2.0-67349251193 10.1007/s00246-008-9370-5
48. Ramkisoensing A. A., Pijnappels D. A., Askar S. F. A., Passier R., Swildens J., Goumans M. J., Schutte C. I., de Vries A. A. F., Scherjon S., Mummery C. L., Schalij M. J., Atsma D. E., Human embryonic and fetal mesenchymal stem cells differentiate toward three different cardiac lineages in contrast to their adult counterparts. PLoS ONE 2011 6 9 2-s2.0-80052568670 10.1371/journal.pone.0024164 e24164
49. Freyman T., Polin G., Osman H., Crary J., Lu M., Cheng L., Palasis M., Wilensky R. L., A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. European Heart Journal 2006 27 9 1114 1122 2-s2.0-33646269967 10.1093/eurheartj/ehi818
50. van der Spoel T. I. G., Lee J. C.-T., Vrijsen K., Sluijter J. P. G., Cramer M. J. M., Doevendans P. A., van Belle E., Chamuleau S. A. J., Non-surgical stem cell delivery strategies and in vivo cell tracking to injured myocardium. International Journal of Cardiovascular Imaging 2011 27 3 367 383 2-s2.0-79958725790 10.1007/s10554-010-9658-4
51. di Nicola M., Carlo-Stella C., Magni M., Milanesi M., Longoni P. D., Matteucci P., Grisanti S., Gianni A. M., Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002 99 10 3838 3843 2-s2.0-0037093058 10.1182/blood.V99.10.3838 (Pubitemid 34534559)
52. le Blanc K., Rasmusson I., Sundberg B., Götherström C., Hassan M., Uzunel M., Ringdén O., Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. The Lancet 2004 363 9419 1439 1441 2-s2.0-2342482526 10.1016/S0140-6736(04)16104-7 (Pubitemid 38586721)
53. Ringdén O., Uzunel M., Rasmusson I., Remberger M., Sundberg B., Lönnies H., Marschall H.-U., Dlugosz A., Szakos A., Hassan Z., Omazic B., Aschan J., Barkholt L., le Blanc K., Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation 2006 81 10 1390 1397 2-s2.0-33744913533 10.1097/01.tp.0000214462.63943.14 (Pubitemid 43847148)
54. le Blanc K., Samuelsson H., Gustafsson B., Remberger M., Sundberg B., Arvidson J., Ljungman P., Lönnies H., Nava S., Ringdén O., Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells. Leukemia 2007 21 8 1733 1738 2-s2.0-34447639255 10.1038/sj.leu.2404777 (Pubitemid 47086763)
55. Tangye S. G., Ma C. S., Brink R., Deenick E. K., The good, the bad and the ugly-TFH cells in human health and disease. Nature Reviews Immunology 2013 13 6 412 426
56. Qian L., Wu Z., Shen J., Advances in the treatment of acute graft-versus-host disease. Journal of Cellular and Molecular Medicine 2013 17 8 966 975
57. Tashiro-Yamaji J., Maeda S., Ikawa M., Okabe M., Kubota T., Yoshida R., Macrophage MHC and T-cell receptors essential for rejection of allografted skin and lymphoma. Transplantation 2013 96 3 251 257
58. Bartholomew A., Sturgeon C., Siatskas M., Ferrer K., McIntosh K., Patil S., Hardy W., Devine S., Ucker D., Deans R., Moseley A., Hoffman R., Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Experimental Hematology 2002 30 1 42 48 2-s2.0-0036142769 10.1016/S0301-472X(01)00769-X (Pubitemid 34059216)
59. Casiraghi F., Azzollini N., Cassis P., Imberti B., Morigi M., Cugini D., Cavinato R. A., Todeschini M., Solini S., Sonzogni A., Perico N., Remuzzi G., Noris M., Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells. Journal of Immunology 2008 181 6 3933 3946 2-s2.0-56149110595
60. Djouad F., Fritz V., Apparailly F., Louis-Plence P., Bony C., Sany J., Jorgensen C., Noël D., Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor α in collagen-induced arthritis. Arthritis and Rheumatism 2005 52 5 1595 1603 2-s2.0-18644370435 10.1002/art.21012 (Pubitemid 40663952)
61. Dazzi F., Krampera M., Mesenchymal stem cells and autoimmune diseases. Best Practice and Research: Clinical Haematology 2011 24 1 49 57 2-s2.0-79952600397 10.1016/j.beha.2011.01.002
62. Singh U. P., Singh N. P., Singh B., Mishra M. K., Nagarkatti M., Nagarkatti P. S., Singh S. R., Stem cells as potential therapeutic targets for inflammatory bowel disease. Frontiers in Bioscience 2010 2 993 1008 2-s2.0-77956620890
63. Tyndall A., van Laar J. M., Stem cells in the treatment of inflammatory arthritis. Best Practice and Research: Clinical Rheumatology 2010 24 4 565 574 2-s2.0-77956150674 10.1016/j.berh.2010.01.008
64. Yan X., Shichita T., Katsumata Y., Matsuhashi T., Ito H., Ito K., Anzai A., Endo J., Tamura Y., Kimura K., Fujita J., Shinmura K., Shen W., Yoshimura A., Fukuda K., Sano M., Deleterious effect of the IL-23/IL-17A axis and gammadeltaT cells on left ventricular remodeling after myocardial infarction. Journal of the American Heart Association 2012 1 5 e004408
65. Aggarwal S., Pittenger M. F., Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005 105 4 1815 1822 2-s2.0-13544249606 10.1182/blood-2004-04-1559 (Pubitemid 40223708)
66. + regulatory T cells. Clinical and Experimental Immunology 2009 156 1 149 160 2-s2.0-61849123247 10.1111/j.1365-2249.2009.03874.x
67. François M., Romieu-Mourez R., Li M., Galipeau J., Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation. Molecular Therapy 2012 20 1 187 195 2-s2.0-84856960632 10.1038/mt.2011.189
68. Ghannam S., Bouffi C., Djouad F., Jorgensen C., Noël D., Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications. Stem Cell Research and Therapy 2010 1 1, article 2 2-s2.0-77958467862 10.1186/scrt2
69. Mándi Y., Vécsei L., The kynurenine system and immunoregulation. Journal of Neural Transmission 2012 119 2 197 209 2-s2.0-84857625769 10.1007/s00702-011-0681-y
70. Najar M., Raicevic G., Boufker H. I., Kazan H. F., Bruyn C. D., Meuleman N., Bron D., Toungouz M., Lagneaux L., Mesenchymal stromal cells use PGE2 to modulate activation and proliferation of lymphocyte subsets: combined comparison of adipose tissue, Wharton's Jelly and bone marrow sources. Cellular Immunology 2010 264 2 171 179 2-s2.0-77955093536 10.1016/j.cellimm.2010.06.006
71. Augello A., Tasso R., Negrini S. M., Amateis A., Indiveri F., Cancedda R., Pennesi G., Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway. European Journal of Immunology 2005 35 5 1482 1490 2-s2.0-18844404360 10.1002/eji.200425405 (Pubitemid 40691430)
72. Stagg J., Pommey S., Eliopoulos N., Galipeau J., Interferon- γ -stimulated marrow stromal cells: a new type of nonhematopoietic antigen-presenting cell. Blood 2006 107 6 2570 2577 2-s2.0-33644799418 10.1182/blood-2005-07-2793 (Pubitemid 43348704)
73. Klyushnenkova E., Mosca J. D., Zernetkina V., Majumdar M. K., Beggs K. J., Simonetti D. W., Deans R. J., McIntosh K. R., T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression. Journal of Biomedical Science 2005 12 1 47 57 2-s2.0-17744365164 10.1007/s11373-004-8183-7 (Pubitemid 40576763)
74. Glennie S., Soeiro I., Dyson P. J., Lam E. W.-F., Dazzi F., Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood 2005 105 7 2821 2827 2-s2.0-15944376184 10.1182/blood-2004-09-3696 (Pubitemid 40446275)
75. + regulatory T cell population during the differentiation process of Th1 and Th17 cells. Stem Cell Research & Therapy 2013 4 3, article 65
76. Li G., Yuan L., Ren X., Nian H., Zhang L., Han Z. C., Li X., Zhang X., The effect of mesenchymal stem cells on dynamic changes of T cell subsets in experimental autoimmune uveoretinitis. Clinical and Experimental Immunology 2013 173 1 28 37
77. Machado C. V., Telles P. D., Nascimento I. L., Immunological characteristics of mesenchymal stem cells. Revista Brasileira de Hematologia e Hemoterapia 2013 35 1 62 67
78. Ma L., Zhou Z., Zhang D., Yang S., Wang J., Xue F., Yang Y., Yang R., Immunosuppressive function of mesenchymal stem cells from human umbilical cord matrix in immune thrombocytopenia patients. Thrombosis and Haemostasis 2012 107 5 937 950 2-s2.0-84860538803 10.1160/TH11-08-0596
79. Yan Y., Zhang G.-X., Gran B., Fallarino F., Yu S., Li H., Cullimore M. L., Rostami A., Xu H., IDO upregulates regulatory T cells via tryptophan catabolite and suppresses encephalitogenic T cell responses in Experimental autoimmune encephalomyelitis. Journal of Immunology 2010 185 10 5953 5961 2-s2.0-78650673114 10.4049/jimmunol.1001628
80. Matsumoto K., Ogawa M., Suzuki J.-I., Hirata Y., Nagai R., Isobe M., Regulatory T lymphocytes attenuate myocardial infarction-induced ventricular remodeling in mice. International Heart Journal 2011 52 6 382 387 2-s2.0-84255169303 10.1536/ihj.52.382
81. Chan C. J., Smyth M. J., Martinet L., Molecular mechanisms of natural killer cell activation in response to cellular stress. Cell Death and Differentiation 2013 10.1038/cdd.2013.26
82. Pradier A., Passweg J., Villard J., Kindler V., Human bone marrow stromal cells and skin fibroblasts inhibit natural killer cell proliferation and cytotoxic activity. Cell Transplantation 2011 20 5 681 691 2-s2.0-79960004933 10.3727/096368910X536545
83. Spaggiari G. M., Capobianco A., Abdelrazik H., Becchetti F., Mingari M. C., Moretta L., Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2. Blood 2008 111 3 1327 1333 2-s2.0-38949183675 10.1182/blood-2007-02-074997 (Pubitemid 351213419)
84. Abumaree M., Al Jumah M., Pace R. A., Kalionis B., Immunosuppressive properties of mesenchymal stem cells. Stem Cell Reviews and Reports 2012 8 2 375 392 2-s2.0-80052181389 10.1007/s12015-011-9312-0
85. Han Z., Jing Y., Zhang S., Liu Y., Shi Y., Wei L., The role of immunosuppression of mesenchymal stem cells in tissue repair and tumor growth. Cell & Bioscience 2012 2 1, article 8
86. Corcione A., Benvenuto F., Ferretti E., Giunti D., Cappiello V., Cazzanti F., Risso M., Gualandi F., Mancardi G. L., Pistoia V., Uccelli A., Human mesenchymal stem cells modulate B-cell functions. Blood 2006 107 1 367 372 2-s2.0-30144440925 10.1182/blood-2005-07-2657 (Pubitemid 43053565)
87. + hemopoietic progenitor cells to differentiate into regulatory dendritic cells through activation of the notch pathway. Journal of Immunology 2008 180 3 1598 1608 2-s2.0-40749110247
88. Gerdoni E., Gallo B., Casazza S., Musio S., Bonanni I., Pedemonte E., Mantegazza R., Frassoni F., Mancardi G., Pedotti R., Uccelli A., Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis. Annals of Neurology 2007 61 3 219 227 2-s2.0-34147126415 10.1002/ana.21076 (Pubitemid 46557346)
89. Traggiai E., Volpi S., Schena F., Gattorno M., Ferlito F., Moretta L., Martini A., Bone marrow-derived mesenchymal stem cells induce both polyclonal expansion and differentiation of B cells isolated from healthy donors and systemic lupus erythematosus patients. Stem Cells 2008 26 2 562 569 2-s2.0-40949119840 10.1634/stemcells.2007-0528 (Pubitemid 351413617)
90. Rasmusson I., le Blanc K., Sundberg B., Ringdén O., Mesenchymal stem cells stimulate antibody secretion in human B cells. Scandinavian Journal of Immunology 2007 65 4 336 343 2-s2.0-33947593728 10.1111/j.1365-3083.2007. 01905.x (Pubitemid 46481102)
91. Yilmaz A., Dietel B., Cicha I., Schubert K., Hausmann R., Daniel W. G., Garlichs C. D., Stumpf C., Emergence of dendritic cells in the myocardium after acute myocardial infarction-implications for inflammatory myocardial damage. International Journal of Biomedical Science 2010 6 1 27 36 2-s2.0-77953428287
92. Jiang X.-X., Zhang Y., Liu B., Zhang S.-X., Wu Y., Yu X.-D., Mao N., Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood 2005 105 10 4120 4126 2-s2.0-18544371666 10.1182/blood-2004-02-0586 (Pubitemid 40656164)
93. Beyth S., Borovsky Z., Mevorach D., Liebergall M., Gazit Z., Aslan H., Galun E., Rachmilewitz J., Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 2005 105 5 2214 2219 2-s2.0-14944339174 10.1182/blood-2004-07-2921 (Pubitemid 40731815)
94. +-derived and monocyte-derived dendritic cells. Journal of Immunology 2006 177 4 2080 2087 2-s2.0-33746898242 (Pubitemid 44200965)
95. Zhang W., Ge W., Li C., You S., Liao L., Han Q., Deng W., Zhao R. C. H., Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells. Stem Cells and Development 2004 13 3 263 271 2-s2.0-2942562525 10.1089/154732804323099190 (Pubitemid 38738368)
96. Zhao Z.-G., Xu W., Sun L., You Y., Li F., Li Q.-B., Zou P., Immunomodulatory function of regulatory dendritic cells induced by mesenchymal stem cells. Immunological Investigations 2012 41 2 183 198 2-s2.0-83655165119 10.3109/08820139.2011.607877
97. Lambert J. M., Lopez E. F., Lindsey M. L., Macrophage roles following myocardial infarction. International Journal of Cardiology 2008 130 2 147 158 2-s2.0-54949106928 10.1016/j.ijcard.2008.04.059
98. Nahrendorf M., Swirski F. K., Aikawa E., Stangenberg L., Wurdinger T., Figueiredo J.-L., Libby P., Weissleder R., Pittet M. J., The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. Journal of Experimental Medicine 2007 204 12 3037 3047 2-s2.0-36549033197 10.1084/jem.20070885 (Pubitemid 350179569)
99. Barin J. G., Rose N. R., Čiháková D., Macrophage diversity in cardiac inflammation: a review. Immunobiology 2012 217 5 468 475 2-s2.0-84858796712 10.1016/j.imbio.2011.06.009
100. 2-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nature Medicine 2009 15 1 42 49 2-s2.0-58149326737 10.1038/nm.1905
101. Dayan V., Yannarelli G., Billia F., Filomeno P., Wang X.-H., Davies J. E., Keating A., Mesenchymal stromal cells mediate a switch to alternatively activated monocytes/macrophages after acute myocardial infarction. Basic Research in Cardiology 2011 106 6 1299 1310 2-s2.0-84856723391 10.1007/s00395-011-0221-9
102. Maggini J., Mirkin G., Bognanni I., Holmberg J., Piazzón I. M., Nepomnaschy I., Costa H., Cañones C., Raiden S., Vermeulen M., Geffner J. R., Mouse bone marrow-derived mesenchymal stromal cells turn activated macrophages into a regulatory-like profile. PLoS ONE 2010 5 2 2-s2.0-77949537626 10.1371/journal.pone.0009252 e9252
103. Raffaghello L., Bianchi G., Bertolotto M., Montecucco F., Busca A., Dallegri F., Ottonello L., Pistoia V., Human mesenchymal stem cells inhibit neutrophil apoptosis: a model for neutrophil preservation in the bone marrow niche. Stem Cells 2008 26 1 151 162 2-s2.0-38349048723 10.1634/stemcells.2007- 0416
104. Quinn K., Henriques M., Parker T., Slutsky A. S., Zhang H., Human neutrophil peptides: a novel potential mediator of inflammatory cardiovascular diseases. American Journal of Physiology-Heart and Circulatory Physiology 2008 295 5 H1817 H1824 2-s2.0-57049188278 10.1152/ajpheart.00472.2008
105. Bujak M., Frangogiannis N. G., The role of TGF- β signaling in myocardial infarction and cardiac remodeling. Cardiovascular Research 2007 74 2 184 195 2-s2.0-34047148354 10.1016/j.cardiores.2006.10.002 (Pubitemid 46517504)
106. Barth M. C., Ahluwalia N., Anderson T. J. T., Hardy G. J., Sinha S., Alvarez-Cardona J. A., Pruitt I. E., Rhee E. P., Colvin R. A., Gerszten R. E., Kynurenic acid triggers firm arrest of leukocytes to vascular endothelium under flow conditions. The Journal of Biological Chemistry 2009 284 29 19189 19195 2-s2.0-67749111891 10.1074/jbc.M109.024042
107. Smith W. B., Noack L., Khew-Goodall Y., Isenmann S., Vadas M. A., Gamble J. R., Transforming growth factor- β 1 inhibits the production of IL-8 and the transmigration of neutrophils through activated endothelium. Journal of Immunology 1996 157 1 360 368 2-s2.0-0029994311 (Pubitemid 26190568)
108. Delarosa O., Lombardo E., Modulation of adult mesenchymal stem cells activity by toll-like receptors: implications on therapeutic potential. Mediators of Inflammation 2010 2010 9 2-s2.0-77954551154 10.1155/2010/865601 865601
109. Liotta F., Angeli R., Cosmi L., Filì L., Manuelli C., Frosali F., Mazzinghi B., Maggi L., Pasini A., Lisi V., Santarlasci V., Consoloni L., Angelotti M. L., Romagnani P., Parronchi P., Krampera M., Maggi E., Romagnani S., Annunziato F., Toll-like receptors 3 and 4 are expressed by human bone marrow-derived mesenchymal stem cells and can inhibit their T-cell modulatory activity by impairing notch signaling. Stem Cells 2008 26 1 279 289 2-s2.0-38349060182 10.1634/stemcells.2007-0454
110. Takeda K., Akira S., Toll-like receptors in innate immunity. International Immunology 2005 17 1 1 14 2-s2.0-12444341944 10.1093/intimm/dxh186
111. Yamamoto M., Takeda K., Current views of toll-like receptor signaling pathways. Gastroenterology Research and Practice 2010 2010 8 2-s2.0-79251563125 10.1155/2010/240365 240365
112. Arslan F., Smeets M. B., O'Neill L. A. J., Keogh B., McGuirk P., Timmers L., Tersteeg C., Hoefer I. E., Doevendans P. A., Pasterkamp G., De Kleijn D. P. V., Myocardial ischemia/reperfusion injury is mediated by leukocytic toll-like receptor-2 and reduced by systemic administration of a novel anti-toll-like receptor-2 antibody. Circulation 2010 121 1 80 90 2-s2.0-74549178528 10.1161/CIRCULATIONAHA.109.880187
113. Chen D., Ma F., Xu S., Yang S., Chen F., Rong L., Chi Y., Zhao Q., Lu S., Han Z., Pang A., Expression and role of toll-like receptors on human umbilical cord mesenchymal stromal cells. Cytotherapy 2013 15 4 423 433
114. Rock K. L., Latz E., Ontiveros F., Kono H., The sterile inflammatory response. Annual Review of Immunology 2010 28 321 342 2-s2.0-77952294609 10.1146/annurev-immunol-030409-101311
115. Matzinger P., An innate sense of danger. Annals of the New York Academy of Sciences 2002 961 341 342 2-s2.0-0036293726 (Pubitemid 34721806)
116. Feng Y., Chao W., Toll-like receptors and myocardial inflammation. International Journal of Inflammation 2011 2011 21 10.4061/2011/170352 170352
117. Faure E., Equils O., Sieling P. A., Thomas L., Zhang F. X., Kirschning C. J., Polentarutti N., Muzio M., Arditi M., Bacterial lipopolysaccharide activates NF- B through toll-like receptor 4 (TLR-4) in cultured human dermal endothelial cells. Differential expression of TLR-4 and TLR-2 in endothelial cells. The Journal of Biological Chemistry 2000 275 15 11058 11063 2-s2.0-0034646695 10.1074/jbc.275.15.11058 (Pubitemid 30212746)
118. Wang Y., Abarbanell A. M., Herrmann J. L., Weil B. R., Manukyan M. C., Poynter J. A., Meldrum D. R., TLR4 inhibits mesenchymal stem cell (MSC) STAT3 activation and thereby exerts deleterious effects on MSC-mediated cardioprotection. PLoS ONE 2010 5 12 2-s2.0-78649967662 10.1371/journal.pone. 0014206 e14206
119. Raicevic G., Rouas R., Najar M., Stordeur P., Id Boufker H., Bron D., Martiat P., Goldman M., Nevessignsky M. T., Lagneaux L., Inflammation modifies the pattern and the function of toll-like receptors expressed by human mesenchymal stromal cells. Human Immunology 2010 71 3 235 244 2-s2.0-76949094176 10.1016/j.humimm.2009.12.005
120. Tomchuck S. L., Zwezdaryk K. J., Coffelt S. B., Waterman R. S., Danka E. S., Scandurro A. B., Toll-like receptors on human mesenchymal stem cells drive their migration and immunomodulating responses. Stem Cells 2008 26 1 99 107 2-s2.0-38349077498 10.1634/stemcells.2007-0563
121. Opitz C. A., Litzenburger U. M., Lutz C., Lanz T. V., Tritschler I., Köppel A., Tolosa E., Hoberg M., Anderl J., Aicher W. K., Weller M., Wick W., Platten M., Toll-like receptor engagement enhances the immunosuppressive properties of human bone marrow-derived mesenchymal stem cells by inducing indoleamine-2,3-dioxygenase-1 via Interferon-b and protein kinase R. Stem Cells 2009 27 4 909 919 2-s2.0-65649089411 10.1002/stem.7
122. Pevsner-Fischer M., Morad V., Cohen-Sfady M., Rousso-Noori L., Zanin-Zhorov A., Cohen S., Cohen I. R., Zipori D., Toll-like receptors and their ligands control mesenchymal stem cell functions. Blood 2007 109 4 1422 1432 2-s2.0-33846914143 10.1182/blood-2006-06-028704 (Pubitemid 46239573)
123. Romieu-Mourez R., François M., Boivin M.-N., Bouchentouf M., Spaner D. E., Galipeau J., Cytokine modulation of TLR expression and activation in mesenchymal stromal cells leads to a proinflammatory phenotype. Journal of Immunology 2009 182 12 7963 7973 2-s2.0-67649209791 10.4049/jimmunol.0803864
124. Waterman R. S., Tomchuck S. L., Henkle S. L., Betancourt A. M., A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an immunosuppressive MSC2 phenotype. PLoS ONE 2010 5 4 2-s2.0-77956420421 10.1371/journal.pone.0010088 e10088
125. Hwa Cho H., Bae Y. C., Jung J. S., Role of toll-like receptors on human adipose-derived stromal cells. Stem Cells 2006 24 12 2744 2752 2-s2.0-33845995756 10.1634/stemcells.2006-0189 (Pubitemid 46053012)
126. Abarbanell A. M., Wang Y., Herrmann J. L., Weil B. R., Poynter J. A., Manukyan M. C., Meldrum D. R., Toll-like receptor 2 mediates mesenchymal stem cell-associated myocardial recovery and VEGF production following acute ischemia-reperfusion injury. American Journal of Physiology-Heart and Circulatory Physiology 2010 298 5 H1529 H1536 2-s2.0-77951804977 10.1152/ajpheart.01087.2009
127. Lombardo E., Delarosa O., Mancheño-Corvo P., Menta R., Ramírez C., Büscher D., Toll-like receptor-mediated signaling in human adipose-derived stem cells: implications for immunogenicity and immunosuppressive potential. Tissue Engineering A 2009 15 7 1579 1589 2-s2.0-67650675375 10.1089/ten.tea.2008.0340
128. Kim H.-S., Shin T.-H., Yang S.-R., Seo M.-S., Kim D.-J., Kang S.-K., Park J.-H., Kang K.-S., Implication of NOD1 and NOD2 for the differentiation of multipotent mesenchymal stem cells derived from human umbilical cord blood. PLoS ONE 2010 5 10 2-s2.0-78149452823 10.1371/journal.pone.0015369 e15369
129. Mo I. F. Y., Yip K. H. K., Chan W. K., Law H. K. W., Lau Y. L., Chan G. C. F., Prolonged exposure to bacterial toxins downregulated expression of toll-like receptors in mesenchymal stromal cell-derived osteoprogenitors. BMC Cell Biology 2008 9, article 52 2-s2.0-54049148607 10.1186/1471-2121-9-52
130. Nurmenniemi S., Kuvaja P., Lehtonen S., Tiuraniemi S., Alahuhta I., Mattila R. K., Risteli J., Salo T., Selander K. S., Nyberg P., Lehenkari P., Toll-like receptor 9 ligands enhance mesenchymal stem cell invasion and expression of matrix metalloprotease-13. Experimental Cell Research 2010 316 16 2676 2682 2-s2.0-77955845289 10.1016/j.yexcr.2010.05.024
131. Tomic S., Djokic J., Vasilijic S., Vucevic D., Todorovic V., Supic G., Colic M., Immunomodulatory properties of mesenchymal stem cells derived from dental pulp and dental follicle are susceptible to activation by toll-like receptor agonists. Stem Cells and Development 2011 20 4 695 708 2-s2.0-79953680762 10.1089/scd.2010.0145
132. van den Berk L. C. J., Jansen B. J. H., Siebers-Vermeulen K. G. C., Roelofs H., Figdor C. G., Adema G. J., Torensma R., Mesenchymal stem cells respond to TNF but do not produce TNF. Journal of Leukocyte Biology 2010 87 2 283 289 2-s2.0-76149131654 10.1189/jlb.0709467
133. Mastri M., Shah Z., McLaughlin T., Greene C. J., Baum L., Suzuki G., Lee T., Activation of toll-like receptor 3 amplifies mesenchymal stem cell trophic factors and enhances therapeutic potency. American Journal of Physiology-Cell Physiology 2012 303 10 C1021 C1033
134. Satoh M., Shimoda Y., Akatsu T., Ishikawa Y., Minami Y., Nakamura M., Elevated circulating levels of heat shock protein 70 are related to systemic inflammatory reaction through monocyte toll signal in patients with heart failure after acute myocardial infarction. European Journal of Heart Failure 2006 8 8 810 815 2-s2.0-33751165458 10.1016/j.ejheart.2006.03.004 (Pubitemid 44779418)
135. Vallejo J. G., Role of toll-like receptors in cardiovascular diseases. Clinical Science 2011 121 1 1 10 2-s2.0-79953303630 10.1042/CS20100539
136. Hua F., Ha T., Ma J., Li Y., Kelley J., Gao X., Browder I. W., Kao R. L., Williams D. L., Li C., Protection against myocardial ischemia/reperfusion injury in TLR4-deficient mice is mediated through a phosphoinositide 3-kinase-dependent mechanism. Journal of Immunology 2007 178 11 7317 7324 2-s2.0-34249787873 (Pubitemid 46847459)
137. Sakata Y., Dong J.-W., Vallejo J. G., Huang C.-H., Baker J. S., Tracey K. J., Tacheuchi O., Akira S., Mann D. L., Toll-like receptor 2 modulates left ventricular function following ischemia-reperfusion injury. American Journal of Physiology-Heart and Circulatory Physiology 2007 292 1 H503 H509 2-s2.0-33846204374 10.1152/ajpheart.00642.2006 (Pubitemid 46105213)